Plus Therapeutics (PSTV) Insider Trading & Ownership $1.29 +0.10 (+8.40%) (As of 11/12/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Plus Therapeutics (NASDAQ:PSTV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.49%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$90,234.90Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$4,053.28 Get PSTV Insider Trade Alerts Want to know when executives and insiders are buying or selling Plus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PSTV Insider Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Plus Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/13/2024Richard J HawkinsDirectorBuy4,000$1.50$6,000.00 9/11/2024Howard ClowesDirectorBuy5,000$1.34$6,700.00 9/10/2024Andrew John Hugh Macintyr SimsCFOBuy4,098$1.27$5,204.46 9/10/2024Marc H HedrickCEOBuy8,000$1.23$9,840.00 5/8/2024Andrew John Hugh Macintyr SimsCFOBuy4,902$2.04$10,000.08 5/8/2024Howard ClowesDirectorBuy9,804$2.04$20,000.16 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/8/2024Marc H HedrickCEOBuy12,255$2.04$25,000.20 11/20/2023Marc H HedrickCEOSell2,068$1.96$4,053.28 11/15/2023Robert P LenkDirectorBuy1,000$1.77$1,770.00 11/13/2023Robert P LenkDirectorBuy4,000$1.43$5,720.00 (Data available from 1/1/2013 forward) PSTV Insider Trading Activity - Frequently Asked Questions Who is on Plus Therapeutics's Insider Roster? The list of insiders at Plus Therapeutics includes Andrew John Hugh Macintyr Sims, Greg Petersen, Howard Clowes, Marc H Hedrick, Richard J Hawkins, and Robert P Lenk. Learn more on insiders at PSTV. What percentage of Plus Therapeutics stock is owned by insiders? 5.49% of Plus Therapeutics stock is owned by insiders. Learn more on PSTV's insider holdings. Which Plus Therapeutics insiders have been buying company stock? The following insiders have purchased PSTV shares in the last 24 months: Andrew John Hugh Macintyr Sims ($15,204.54), Greg Petersen ($34,000.00), Howard Clowes ($49,780.15), Marc H Hedrick ($34,840.20), Richard J Hawkins ($6,000.00), and Robert P Lenk ($20,732.50). How much insider buying is happening at Plus Therapeutics? Insiders have purchased a total of 91,947 PSTV shares in the last 24 months for a total of $160,557.39 bought. Which Plus Therapeutics insiders have been selling company stock? The following insider sold PSTV shares in the last 24 months: Marc H Hedrick ($4,053.28). How much insider selling is happening at Plus Therapeutics? Insiders have sold a total of 2,068 Plus Therapeutics shares in the last 24 months for a total of $4,053.28 sold. Plus Therapeutics Key ExecutivesDr. Marc H. Hedrick M.B.A. (Age 61)M.D., President, CEO & Director Compensation: $945.34kMr. Andrew J. Sims CPA (Age 51)VP of Finance & CFO Compensation: $498.51kDr. Norman D. LaFrance FACNP (Age 76)FACP, M.D., Chief Medical Officer & Senior VP Compensation: $646.02kMs. Desiree Smith (Age 60)Corporate Controller, Principal Financial & Accounting Officer Dr. John K. Fraser (Age 63)Chief Scientist More Insider Trading Tools from MarketBeat Related Companies NXL Insider Ownership DRIO Insider Ownership MDAI Insider Ownership BSGM Insider Ownership IRIX Insider Ownership XAIR Insider Ownership LFWD Insider Ownership NXGL Insider Ownership LYRA Insider Ownership NEPH Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Here’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock This page (NASDAQ:PSTV) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredYou just voted for a financial crisisI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
